Mary Lynne Hedley
CIK 1340823 · President & COO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.80M
Companies
8
Total Filings
114
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VEEV | Director | 7,152 | $159.54 | $1.14M | -$146.4K | 41 | 2026-06-03 |
| LLY | Director | 2,350 | $1133.00 | $2.66M | $0 | 44 | 2025-12-16 |
| CNTA | Director | — | $39.72 | — | $0 | 4 | 2025-06-24 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | — | $15.90 | — | $0 | 4 | 2020-06-23 |
| TESARO, Inc. (TSRO) Delisted | President & COO | 0 | — | — | -$909.0K | 10 | 2019-01-22 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 3,700 | $4.97 | $18.4K | $0 | 2 | 2018-06-22 |
| Receptos, Inc. (RCPT) Delisted | Director | 0 | — | — | $0 | 2 | 2015-08-27 |
| MGI PHARMA INC (MOGN) Delisted | Exec VP & Chief Scientific Off | 18,250 | — | — | $0 | 5 | 2008-01-25 |
Recent Filings · Page 4 of 12
114 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-18 | LLY | Grant (A) | +11 | $9.7K | EDGAR |
| 2024-06-03 | VEEV | Exer (M) | +302 | $0 | EDGAR |
| 2024-05-21 | LLY | Grant (A) | +13 | $10.2K | EDGAR |
| 2024-04-16 | LLY | Grant (A) | +13 | $9.8K | EDGAR |
| 2024-03-19 | LLY | Grant (A) | +13 | $9.9K | EDGAR |
| 2024-03-05 | VEEV | Exer (M) | +302 | $0 | EDGAR |
| 2024-02-21 | LLY | Grant (A) | +13 | $9.8K | EDGAR |
| 2024-01-17 | LLY | Grant (A) | +16 | $10.2K | EDGAR |
| 2023-12-28 | VEEV | Sell (S) | −83 | -$15.9K | EDGAR |
| 2023-12-19 | LLY | Grant (A) | +17 | $9.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.